Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
A trial to evaluate the safety of long term treatment with nintedanib in patients with scleroderma related lung fibrosis.
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Contributors
Shah, Ankoor
Principal Investigator
Start/End
May 8, 2018 - August 14, 2021